8.12

Nonlinear Pharmacokinetics: Role of Transporters

441 views01:27 min

Drug kinetics, under nonlinear changes influenced by transporter proteins, are pivotal in drug distribution.

These cellular transporters in cells modulate local drug concentrations through facilitated influx or efflux.

For instance, xenobiotic transporter expression, susceptible to age and gender influences, can potentially impact the pharmacokinetic linearity of the drug.

Polymorphisms in drug transporters contribute to variations in drug toxicity and efficacy, altering pharmacokinetics.

In the liver, the interplay between drug transporters and enzymes can significantly impact the pharmacokinetic linearity of hepatic drugs.

In the intestine, ABC transporters influence bioavailability and linearity of absorption, while bile acid transporters regulate drug movement and elimination.

Various organic anion and cation drug transporters in the kidney can alter the linearity of systemic drug elimination.

The action of breast cancer resistance proteins is considered to achieve pharmacokinetic linearity and suitable dosing in cancer therapy.

Understanding the impact of transporters on pharmacokinetics can improve the safety and efficacy of drug dosing.

Overview

Loading...

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.

Polymorphisms occurring in drug transporters can alter pharmacokinetics, affecting drug toxicity and efficacy. The interplay between drug transporters and enzymes in the liver is significant in determining the systemic linearity of drug response. Similarly, in the intestine, ATP-binding cassette and bile acid transporters influence drug absorption, bioavailability, and the linearity of absorption.

Various organic anion and cation drug transporters in the kidney can significantly alter the linearity of systemic drug elimination. Additionally, breast cancer resistance proteins are instrumental in drug linearity and require careful consideration when establishing dosing strategies in cancer therapy.

Moreover, drug-drug interactions involving transporters can potentially disrupt clinical relevance, pharmacokinetics, pharmacodynamics, and toxicity, shifting from linear to nonlinear kinetics. The abundant presence of organic anion and cation drug transporters in the kidney also contributes to alterations in the linearity of systemic drug elimination.

Furthermore, P-glycoprotein, a multidrug resistance protein, plays a pivotal role in determining drug concentration within cells, exerting a considerable influence on pharmacokinetic linearity. Mammalian oligopeptide transporters also contribute significantly to drug absorption and distribution, impacting drug linearity.

Overall, understanding the impact of transporters on pharmacokinetics is essential for optimizing drug dosing, improving safety, and enhancing efficacy. By understanding the intricate mechanisms through which transporters modulate drug kinetics, healthcare professionals can make informed decisions to maximize therapeutic outcomes.

Transcript

Key Terms and Definitions

Learning Objectives

Questions that this video will help you answer

Explore More Videos

Nonlinear Pharmacokinetics

Drug Transporters

Drug Distribution

Xenobiotic Transporters

Drug Absorption

Drug Elimination

Drug Drug Interactions

Pharmacokinetic Linearity

Organic Anion Transporters